Relation between short-term fine-particulate matter exposure and onset of myocardial infarction

Jeffrey Sullivan1, Lianne Sheppard, Astrid Schreuder

  • 1University of Washington, Seattle, Washington 98105, USA. sulijh@u.washington.edu

Abstract

Insights

This study found no consistent link between fine particulate matter air pollution and the onset of myocardial infarction (MI). Researchers observed no increased risk even in individuals with existing heart conditions or common cardiovascular risk factors.

Area of Science:

  • Environmental Health
  • Cardiovascular Epidemiology
  • Air Pollution Research

Background:

  • Epidemiologic studies suggest a correlation between elevated fine particulate matter (PM2.5) air pollution and increased incidence of cardiovascular morbidity and myocardial infarction (MI).
  • These findings imply a potential role for particulate matter in triggering acute MI events.

Purpose of the Study:

  • To investigate the association between the timing of MI onset and preceding hourly levels of fine particulate matter.
  • To determine if short-term exposure to fine particulate matter triggers acute myocardial infarction.

Main Methods:

  • A case-crossover study design was employed, analyzing 5793 confirmed acute MI cases from King County, Washington (1988-1994).
  • Hourly fine particulate matter data, measured by nephelometry, were linked to MI onset times.
  • Exposure levels in the 1, 2, 4, and 24 hours preceding MI onset were compared to time-stratified referent exposures.

Main Results:

  • A 10-microg/m increase in fine particulate matter one hour before MI onset showed a relative risk of 1.01 (95% CI=0.98-1.05), indicating no significant association.
  • Similar lack of association was observed for pollutant levels at other time points.
  • No increased risk was detected in patients with pre-existing cardiac disease or when stratified by hypertension, diabetes, or smoking status.

Conclusions:

  • The study found no consistent association between ambient fine particulate matter levels and the risk of myocardial infarction onset.
  • While a very small effect cannot be entirely ruled out, the current evidence does not support a significant link.

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...